Serum p53 antibodies in correlation to other biological parameters of breast cancer

Vousden, 2002, Live or let die: the cell’s response to p53, Nat. Rev. Cancer, 2, 594, 10.1038/nrc864 Vogelstein, 2000, Surfing the p53 network, Nature, 408, 307, 10.1038/35042675 Soussi, 2000, p53 website and analysis of p53 gene mutations in human cancer: forging a link between epidemiology and carcinogenesis, Hum. Mutat., 15, 105, 10.1002/(SICI)1098-1004(200001)15:1<105::AID-HUMU19>3.0.CO;2-G Soussi, 2001, Assessing TP53 status in human tumours to evaluate clinical outcome, Nat. Rev. Cancer, 1, 233, 10.1038/35106009 Soussi, 2000, p53 antibodies in the sera of patients with various types of cancer: a review, Cancer Res., 60, 1777 Lubin, 1993, Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53–distribution on primary structure and exposure on protein surface, Cancer Res., 53, 5872 Schlichtholz, 1994, Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein, Br. J. Cancer, 69, 809, 10.1038/bjc.1994.159 Vennegoor, 1997, Autoantibodies to p53 in ovarian cancer patients and healthy women: a comparison between whole p53 protein and 18-mer peptides for screening purposes, Cancer Lett., 116, 93, 10.1016/S0304-3835(97)00168-7 Lubin, 1995, p53 antibodies in patients with various types of cancer: assay, identification and characterization, Clinical Cancer Res., 1, 1463 Crawford, 1982, Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer, Int. J. Cancer, 30, 403, 10.1002/ijc.2910300404 Davidoff, 1992, Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers, Proc. Natl. Acad. Sci. U.S.A., 89, 3439, 10.1073/pnas.89.8.3439 Labrecque, 1993, Analysis of the anti-p53 antibody response in cancer patients, Cancer Res., 53, 3468 Tilkin, 1995, Primary proliferative t cell response to wild-type p53 protein in patients with breast cancer, Eur. J. Immunol., 25, 1765, 10.1002/eji.1830250642 Mudenda, 1994, The relationship between serum p53 autoantibodies and characteristics of human breast cancer, Br. J. Cancer, 69, 1115, 10.1038/bjc.1994.219 Peyrat, 1995, Prognostic significance of circulating p53 antibodies in patients undergoing surgery for locoregional breast cancer, Lancet, 345, 621, 10.1016/S0140-6736(95)90523-5 American Joint Committee on Cancer. Manual for staging of cancer. 5th ed. Philadelphia: Lippincott-Raven; 1997. Winter, 1992, Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation, Cancer Res., 52, 4168 Hammel, 1999, Correlations between p53-protein accumulation, serum antibodies and gene mutation in colorectal cancer, Int. J. Cancer, 81, 712, 10.1002/(SICI)1097-0215(19990531)81:5<712::AID-IJC7>3.0.CO;2-0 Guinee, 1995, Gender comparisons in human lung cancer: analysis of p53 mutations, anti-p53 serum antibodies and c-erbB-2 expression, Carcinogenesis, 16, 993, 10.1093/carcin/16.5.993 Schlichtholz, 1992, The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot, Cancer Res., 52, 6380 Cattoretti, 1988, p53 expression in breast cancer, Int. J. Cancer, 41, 178, 10.1002/ijc.2910410204 Naidu, 1998, Immunohistochemical analysis of p53 expression in primary breast carcinomas, Anticancer Res., 18, 65 Cowan, 1991, Immunohistochemical and other features of breast carcinomas presenting clinically compared with those detected by cancer screening, Br. J. Cancer, 64, 780, 10.1038/bjc.1991.398 Thor, 1989, Analysis of c-erbB-2 expression in breast carcinomas with clinical follow-up, Cancer Res., 49, 7147 Temmim, 2001, Immunohistochemical detection of p53 protein expression in breast cancer in young Kuwaiti women, Anticancer Res., 21, 743 Nakajima, 1999, Detection of preoperative serum anti-p53 antibodies in gastric cancer, Tumor Biol., 20, 147, 10.1159/000030057 Takeda, 1999, Detection of serum p53 antibodies in colorectal cancer patients and the clinical significance of postoperative monitoring, Gan To Kagaku Ryoho, 26, 2189 Lubin, 1995, Serum p53 antibodies as early markers of lung cancer, Nature Med., 1, 701, 10.1038/nm0795-701 Trivers, 1996, Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer, Clin. Cancer Res., 2, 1767 Zalcman, 1998, Monitoring of p53 auto antibodies in lung cancer during therapy: relationship to response to treatment, Clin. Cancer Res., 4, 1359